01—Abstract
Summary
Summary of the 8-K filed May 1, 2024. Cited figures are marked; the original filing is the authoritative source.
Marriott International (MAR) reported first quarter 2024 results on May 1, 2024, showing solid top-line momentum and a raised full-year earnings outlook, though reported earnings declined year over year.
Worldwide comparable systemwide constant-dollar RevPAR rose 4.2%, led by international markets (+11.1%, with Asia Pacific excluding China up nearly 17%), while U.S. & Canada RevPAR grew a more modest 1.5%. Gross fee revenues rose 7% to $1,210 milliona, and adjusted EBITDA increased 4% to $1,142 million. Adjusted diluted EPS was $2.13 versus $2.09 a year earlier, but reported diluted EPS fell 21% to $1.93 and net income fell 25% to $564 million, largely due to a $103 million tax benefit in the prior-year quarter and higher G&A and interest expense.
Rooms growth was strong, with roughly 46,000 net rooms added, about 37,000 of which came from the MGM Resorts agreement that launched the MGM Collection with Marriott Bonvoy. The development pipeline reached nearly 547,000 rooms, and about 202,000 rooms were under construction. Capital returns remain a focus: Marriott repurchased $1.2 billionb of stock in the quarter and has returned $1.7 billion year to date through April 26.
Total debt rose to $12.7 billionc from $11.9 billion at year-end 2023. Management raised full-year 2024 adjusted EBITDA guidance to $4.96–$5.09 billion and adjusted EPS guidance to $9.31–$9.65, and expects capital returns of $4.2–$4.4 billion.
Full-year RevPAR growth is guided at 3–5%d, and year-end net rooms growth at 5.5–6%. Investors should weigh the asset-light model's resilience against rising debt, higher corporate costs, and the reliance on international growth.
02—Key points
Key Highlights
- Worldwide comparable RevPAR grew 4.2% in Q1 2024; international RevPAR rose 11.1% while U.S. & Canada rose only 1.5%, with group demand a standout.
- Adjusted diluted EPS rose 2% to $2.13, but reported diluted EPS fell 21% to $1.93 and reported net income fell 25% to $564 million, reflecting the absence of a prior-year $100 million tax benefit.
- Adjusted EBITDA increased 4% to $1,142 million; gross fee revenues rose 7% to $1,210 million, driven by RevPAR gains and unit growth.
- Net rooms grew by roughly 46,000 in the quarter, about 37,000 from the MGM Resorts agreement; the pipeline stands at nearly 547,000 rooms.
- Full-year 2024 guidance raised: adjusted EBITDA of $4.96–$5.09 billion and adjusted EPS of $9.31–$9.65, with the company guiding 3–5% full-year RevPAR growth.
- General, administrative, and other expenses rose 29% to $261 million on higher compensation and litigation costs, and interest expense rose 29% to $163 million on higher debt.
- Marriott repurchased $1.2 billion of stock in Q1 and plans $4.2–$4.4 billion in total 2024 shareholder returns; total debt rose to $12.7 billion.
03—Questions
Frequently Asked Questions
Why did reported EPS and net income decline if the company's operating results improved?
The prior-year quarter included a $103 million tax benefit from the release of reserves after a tax audit was completed, and a $100 million (about $0.32 per share) special tax item excluded from adjusted results. Reported Q1 2024 provision for income taxes was $163 million (22% effective rate) versus $87 million (10%) a year earlier. Adjusted EPS, which excludes these items, actually rose to $2.13 from $2.09.
How strong is the MGM Collection with Marriott Bonvoy contribution to growth?
The MGM Resorts agreement added about 37,000 rooms in Q1 2024, which accounts for most of the roughly 46,000 net rooms added in the quarter. Management described early booking pace and loyalty point redemptions as outstanding. Because these rooms are excluded from comparable RevPAR, the contribution shows up in net rooms and fee growth rather than in same-store RevPAR.
Is Marriott's regional demand balanced?
No. International markets drove the quarter, with systemwide RevPAR up 11.1%, led by Asia Pacific excluding China (up nearly 17%). U.S. & Canada RevPAR rose only 1.5% after demand normalized, though group RevPAR grew nearly 5%. Investors should note the U.S. & Canada softness, which represents a larger share of the room base.
Is the company's leverage increasing with its capital returns?
Total debt rose to $12.7 billion at quarter-end from $11.9 billion at year-end 2023, while cash was $0.4 billion. Interest expense increased to $163 million from $126 million. Shareholder returns of $1.7 billion year to date through April 26 were funded partly by additional borrowing, so the balance sheet trend warrants monitoring.
What are the main risks to the raised 2024 outlook?
Guidance excludes cost reimbursement revenue, reimbursed expenses, merger-related charges, and potential asset sales, which management cannot forecast reliably. Guidance also assumes no asset sales. The U.S. & Canada demand normalization, rising G&A and litigation costs, higher interest expense, and the forward-looking uncertainties described in the company's SEC filings could all affect results.
04—Continue